Related Experiment Video
Updated: Jun 25, 2025
08:41
Assessment of Vascular Tone Responsiveness using Isolated Mesenteric Arteries with a Focus on Modulation by Perivascular Adipose Tissues
Published on: June 3, 2019
9.8K
Comparative assessment of CacyBP/SIP, β-catenin and cannabinoid receptors in the adrenals of hypertensive rats
Magdalena Smereczańska1, Natalia Domian1, Alicja Lewandowska1
1Department of Histology and Cytophysiology, Medical University of Bialystok, Bialystok, Poland.
Journal of Cellular and Molecular Medicine
|May 23, 2024
Summary
Hypertension alters adrenal gland proteins like CacyBP/SIP (calcyclin-binding protein/small intensely-colored protein) and β-catenin. Cannabinoid receptors CB1 and CB2 also show differential expression in hypertensive rats.
Area of Science:
- Endocrinology
- Molecular Biology
- Cardiovascular Research
Background:
- Arterial hypertension is linked to homeostatic disorders.
- CacyBP/SIP, β-catenin, and endocannabinoids play crucial roles in organ function.
- Understanding their role in hypertension is vital for therapeutic strategies.
Purpose of the Study:
- To investigate the expression and distribution of CacyBP/SIP, β-catenin, CB1, and CB2 in the adrenal glands of rats with different types of hypertension.
- To compare these expressions between hypertensive models and normotensive controls.
Main Methods:
- The study utilized adrenal glands from rats with spontaneous (SHR) and renovascular (2K1C) hypertension.
- Immunohistochemistry and real-time PCR were employed to detect protein and gene expression.
- Analysis focused on CacyBP/SIP, β-catenin, CB1, and CB2.
Main Results:
- All hypertensive groups exhibited reduced CacyBP/SIP gene expression and immunoreactivity compared to normotensive rats.
- 2K1C rats showed decreased β-catenin, CB1, and CB2 expression.
- SHR rats displayed weak/negative β-catenin and CB1 reactions, but increased CB2 expression.
Conclusions:
- This study reveals distinct expression patterns of CacyBP/SIP, β-catenin, and cannabinoid receptors in the adrenal glands of rats with primary (SHR) versus secondary (2K1C) hypertension.
- These findings highlight molecular differences in adrenal gland response to various hypertensive etiologies.
- The results provide novel insights into the molecular mechanisms underlying hypertension-related adrenal dysfunction.
More Related Videos
Related Concept Videos
01:26Adrenergic Receptors: β Subtype
1.6K
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
1.6K
01:31Adrenergic Receptors: ɑ Subtype
1.5K
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
1.5K
01:17Antihypertensive Drugs: Action of β1 Blockers
429
β1-receptors are primarily located in the heart and kidneys. In cardiac myocytes, these receptors interact with neurotransmitters released by the sympathetic nervous system during heightened activity or danger. As a result, β1-receptors get activated, initiating a series of biochemical processes. Excessive activation of beta receptors due to chronic stress can abnormally increase heart rate and contractility, resulting in high blood pressure or hypertension. To counteract this,...
429
01:27Adrenergic Receptors (Adrenoceptors): Classification
2.5K
Adrenergic receptors, or adrenoceptors, respond to the autonomic neurotransmitter noradrenaline and other endogenous catecholamine agonists. They are classified into two main families, α and β, based on their pharmacological response and are further subdivided depending on their location, elicited response, and affinity to specific agonists or antagonists.
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
α-Adrenoceptors
α-Adrenoceptors are classified into two main subtypes: α1 and α2. The α1 adrenoceptors,...
2.5K
01:30Antihypertensive Drugs: Angiotensin II Receptor Blockers
714
In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
714
01:30Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
618
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
618